Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.
Saved in:
| Title: | Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis. |
|---|---|
| Authors: | Vogel A; Hannover Medical School, Hannover, Germany., Finn RS; Division of Hematology Oncology, Department of Medicine, University of California, Los Angeles, CA, USA., Blanchet Zumofen MH; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Heuser C; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Alvarez JS; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Leibfried M; Genentech Inc., South San Francisco, CA, USA., Mitchell CR; Mtech Access Limited, Bicester, UK., Batson S; Mtech Access Limited, Bicester, UK., Redhead G; Mtech Access Limited, Bicester, UK., Gaillard VE; Hannover Medical School, Hannover, Germany., Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. |
| Source: | Liver cancer [Liver Cancer] 2023 Jul 29; Vol. 12 (6), pp. 510-520. Date of Electronic Publication: 2023 Jul 29 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: eCollection Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2235-1795 |
|---|---|
| DOI: | 10.1159/000533166 |
